Interest in {dimethyltryptamine | copyright | this substance ) is certainly generating a notable dialogue across Canada. Until recently considered the fringes of study , copyright is now finding greater scrutiny from academics, clinicians, and the general public . Legislative guidelines surrounding its prospective use – particularly in clinical s